Cary J Claiborne - Net Worth and Insider Trading

Cary J Claiborne Net Worth

The estimated net worth of Cary J Claiborne is at least $51,552 dollars as of 2024-11-13. Cary J Claiborne is the Former Chief Financial Officer of Sucampo Pharmaceuticals Inc and owns about 2,864 shares of Sucampo Pharmaceuticals Inc (SCMP) stock worth over $51,552. Details can be seen in Cary J Claiborne's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Cary J Claiborne has not made any transactions after 2014-12-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Cary J Claiborne

To

Cary J Claiborne Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Cary J Claiborne owns 2 companies in total, including Adial Pharmaceuticals Inc (ADIL) , and LadRx Corp (LADX) .

Click here to see the complete history of Cary J Claiborne’s form 4 insider trades.

Insider Ownership Summary of Cary J Claiborne

Ticker Comapny Transaction Date Type of Owner
ADIL Adial Pharmaceuticals Inc 2021-11-02 director
LADX LadRx Corp 2022-07-27 director

Cary J Claiborne Latest Holdings Summary

Cary J Claiborne currently owns a total of 1 stock. Cary J Claiborne owns 2,864 shares of Sucampo Pharmaceuticals Inc (SCMP) as of December 16, 2014, with a value of $51,552.

Latest Holdings of Cary J Claiborne

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SCMP Sucampo Pharmaceuticals Inc 2014-12-16 2,864 18.00 51,552

Holding Weightings of Cary J Claiborne


Cary J Claiborne Form 4 Trading Tracker

According to the SEC Form 4 filings, Cary J Claiborne has made a total of 0 transactions in Sucampo Pharmaceuticals Inc (SCMP) over the past 5 years. The most-recent trade in Sucampo Pharmaceuticals Inc is the sale of 50,000 shares on December 16, 2014, which brought Cary J Claiborne around $645,500.

Insider Trading History of Cary J Claiborne

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Cary J Claiborne Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Cary J Claiborne Ownership Network

Ownership Network List of Cary J Claiborne

No Data

Ownership Network Relation of Cary J Claiborne

Insider Network Chart

Cary J Claiborne Owned Company Details

What does Adial Pharmaceuticals Inc do?

Who are the key executives at Adial Pharmaceuticals Inc?

Cary J Claiborne is the director of Adial Pharmaceuticals Inc. Other key executives at Adial Pharmaceuticals Inc include director & 10 percent owner & Chief Executive Officer Stilley William B. Iii , director & 10 percent owner Bankole A. Johnson , and COO and CFO Joseph Truluck .

Adial Pharmaceuticals Inc (ADIL) Insider Trades Summary

Over the past 18 months, Cary J Claiborne made no insider transaction in Adial Pharmaceuticals Inc (ADIL). Other recent insider transactions involving Adial Pharmaceuticals Inc (ADIL) include a net purchase of 700 shares made by Kevin Schuyler ,

In summary, during the past 3 months, insiders sold 0 shares of Adial Pharmaceuticals Inc (ADIL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Adial Pharmaceuticals Inc (ADIL) were sold and 700 shares were bought by its insiders, resulting in a net purchase of 700 shares.

Adial Pharmaceuticals Inc (ADIL)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Adial Pharmaceuticals Inc Insider Transactions

No Available Data

Cary J Claiborne Mailing Address

Above is the net worth, insider trading, and ownership report for Cary J Claiborne. You might contact Cary J Claiborne via mailing address: 3056 Seneca Chief Trail, Ellicott City Md 21042.